OCULAR GENETICS IS CHANGING PAEDIATRIC OPHTHALMOLOGY

OCULAR GENETICS IS CHANGING PAEDIATRIC OPHTHALMOLOGY
Arthur Cummings
Published: Friday, September 4, 2015

More support for ocular genetics training programmes, and more collaboration with ophthalmologists, are needed to realise the tremendous promise of genetic research to improve ophthalmic care, Alex V Levin MD, Chief of Paediatric Ophthalmology and Ocular Genetics at Wills Eye Hospital, Philadelphia, USA, told the 3rd World Congress of Paediatric Ophthalmology and Strabismus in Barcelona.

Dr Levin noted that the first examples of many categories of genetic disorders have ocular manifestations. These include piebaldism, the first autosomal dominant disorder described, and red-green colour blindness, the first X-linked recessive disorder other than haemophilia.

“Eye genetics rules. We are the first in so many areas. Why?” Dr Levin asked.

It may be that genetic variations are more easily observed in the transparent tissues of the eye than in other organs. For example, lyonization, in which heterozygous X-linked genes are randomly expressed in half the cells of females, can conceal a recessive X-linked disease such as ocular albinism in most body parts. But it appears as a mud-splattered pattern on the retina, where expression of the recessive gene is skewed, Dr Levin said.

Genetic research is leading to promising treatments for previously incurable disease, Dr Levin said. “When a 12-year-old comes in with retinitis pigmentosa we no longer have to say ‘sorry’, we can say it will be curable within your lifetime.”

But genetic diagnosis and counselling requires tremendous expertise and exhaustive effort tracing family histories and genetic tests – resources commonly available only in academic settings. More training programmes are needed to expand the supply of ocular geneticists, which currently stands at about 70 worldwide, Dr Levin said.

Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...